Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Imunon Inc IMNN

Healthcare Biotechnology
Imunon, Inc. is a clinical-stage biotechnology company. The Company is focused on advancing a portfolio of treatments that harness the body’s natural mechanisms across an array of human diseases. The Company is developing non-viral Deoxyribonucleic acid (DNA) technology across four modalities. The first modality, TheraPlas, is developed for the coding of proteins and cytokines in the treatment... see more

Recent & Breaking News (NDAQ:IMNN)

In The Know, Smart Investing in CLNT, AFFY, TSLA and CLSN

Marketwired June 18, 2013

Special Situation Coming Soon, A Look Inside CLNT, AFFY, TSLA and CLSN

Marketwired June 17, 2013

RDInvesting Provides Investors with Free In-Depth Equity Reports on CDXS, CLSN, MYGN and ZTS

Accesswire June 17, 2013

The Rosen Law Firm Announces Investigation of Securities Claims Against Celsion Corp. - CLSN

Business Wire June 17, 2013

Special Offer for Shareholders of CLNT, AFFY, TSLA and CLSN

Marketwired June 14, 2013

The Straight Truth, Investing in CLNT, AFFY, TSLA and CLSN

Marketwired June 13, 2013

Celsion Corporation Issues Statement Regarding Misleading Blog Entry

PR Newswire June 12, 2013

Strategy Behind Our Success, We Get in Early: CLNT, AFFY, TSLA and CLSN

Marketwired June 12, 2013

Secrets to Making Money in CLNT, AFFY, CERP and CLSN

Marketwired June 10, 2013

Key to Success, How to Profit: CLNT, AFFY, TSLA and CLSN

Marketwired June 7, 2013

Perfect Trade Setups, How to Play FMCC, FNMA, XUII and CLSN

Marketwired June 6, 2013

The Real Story Behind DAL, GNW, HMA and CLSN

Marketwired June 5, 2013

InvestorsGuru.com 21 Filtered Mid-Day Market Movers Recap

Investors Guru June 2, 2013

Celsion Corporation Announces $9.83 Million Registered Direct Offering

PR Newswire May 31, 2013

Regulatory Wins, Leadership Changes, and New Partnerships Creating Healthy Prospects - Research Report on Gilead, Biogen Idec, GlaxoSmithKline, Viropharma, and Celsion

PR Newswire May 31, 2013

Free Research Reports on CLSN, GOV, RVLT and TFM Issued by the Bedford Report

Marketwired May 30, 2013

Celsion Announces ThermoDox® HEAT Study Findings to be presented at the 2013 European Conference on Interventional Oncology (ECIO) in Budapest, Hungary on June 19 and 20, 2013

PR Newswire May 30, 2013

Before the Crowd, How We Found QCOM, SCHW, CLSN and NRG

Marketwired May 29, 2013

Celsion Announces Issuance of Additional Patents Covering ThermoDox® Technologies

PR Newswire May 22, 2013

Celsion's ThermoDox® HEAT Study Findings Reviewed at the 9th Annual World Conference on Interventional Oncology (WCIO)

PR Newswire May 17, 2013